Patents Assigned to Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
  • Publication number: 20130079469
    Abstract: A copolymer containing, in addition to recurring elements of a sulfonated poly(arylene) containing exclusively recurring structural element(s) of the general formulas —[—Ar1(SO3M)n-X—]— and —[—Ar2(SO3M)n-Y—]—, wherein X and Y, which are identical or different from each other, each represent an electron-acceptor group, Ar1 and Ar2, which are either identical or different from each other, represent an aromatic or heteroaromatic ring system with 5-18 ring atoms; wherein the aromatic or heteroaromatic ring system, in addition to the SO3M and the substituents X and Y, optionally comprises additional substituents which are not electron-donor groups; M represents monovalent cation and n is an integral number between 1 and 4; and wherein X, Y, Ar1, Ar2, M and n can be identical or different in various structural elements, independently of each other, one or several additional elements of at least one additional monomer or macromonomer.
    Type: Application
    Filed: November 16, 2012
    Publication date: March 28, 2013
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e V.
    Inventor: Max-Planck-Gesellschaft zur Forderung der Wisse
  • Patent number: 8394628
    Abstract: The present invention relates to a Drosophila in vitro system which was used to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore, when these 21-23 nt fragments are purified and added back to Drosophila extracts, they mediate RNA interference in the absence of long dsRNA. Thus, these 21-23 nt fragments are the sequence-specific mediators of RNA degradation. A molecular signal, which may be their specific length, must be present in these 21-23 nt fragments to recruit cellular factors involved in RNAi. This present invention encompasses these 21-23 nt fragments and their use for specifically inactivating gene function. The use of these fragments (or chemically synthesized oligonucleotides of the same or similar nature) enables the targeting of specific mRNAs for degradation in mammalian cells, where the use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: March 12, 2013
    Assignees: University of Massachusetts, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V.
    Inventors: Thomas Tuschl, Phillip D. Zamore, Phillip A. Sharp, David P. Bartel
  • Patent number: 8384714
    Abstract: A variety of methods, devices and storage mediums are implemented for creating digital representations of figures. According to one such computer implemented method, a volumetric representation of a figure is correlated with an image of the figure. Reference points are found that are common to each of two temporally distinct images of the figure, the reference points representing movement of the figure between the two images. A volumetric deformation is applied to the digital representation of the figure as a function of the reference points and the correlation of the volumetric representation of the figure. A fine deformation is applied as a function of the coarse/volumetric deformation. Responsive to the applied deformations, an updated digital representation of the figure is generated.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: February 26, 2013
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Edilson De Aguiar, Carsten Stoll, Christian Theobalt, Hans-Peter Seidel, Sebastian Thrun
  • Patent number: 8372968
    Abstract: Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). Using a Drosophila in vitro system, we demonstrate that 19-23 nt short RNA fragments are the sequence-specific mediators of RNAi. The short interfering RNAs (siRNAs) are generated by an RNase III-like processing reaction from long dsRNA. Chemically synthesized siRNA duplexes with overhanging 3? ends mediate efficient target RNA cleavage in the lysate, and the cleavage site is located near the center of the region spanned by the guiding siRNA. Furthermore, we provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the produced siRNP complex.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: February 12, 2013
    Assignees: Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V., Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research, University of Massachusetts
    Inventors: Thomas Tuschl, Sayda Mahgoub Elbashir, Winfried Lendeckel
  • Patent number: 8362414
    Abstract: The invention relates to a method and an apparatus for providing a sample for a subsequent analysis of the sample, particularly for analyzing biomolecules, comprising the following steps: generating a free micro liquid jet in an environment having a predetermined pressure, wherein the micro liquid jet contains a carrier liquid and the sample to be analyzed, and dispersing the micro liquid jet into droplets containing the sample, wherein the environment surrounding the micro liquid jet is a gaseous environment in which the pressure is above vacuum conditions.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: January 29, 2013
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V, Georg-August-Universitat Gottingen Stiftung des Offentlichen Rechts
    Inventors: Ales Charvat, Henning Urlaub, Bernd Abel, Erdmann Rapp
  • Patent number: 8357313
    Abstract: The invention relates to a new class of luminescent substances (phosphorous) based on an universally dopable matrix made of an amorphous, at the most partially crystalline network of the elements P, Si, B, Al and N, preferably the composition Si3B3N7. Optical excitation and emission can be varied in this system over the entire practically relevant field by incorporation of any cationic activators, alone or in combination, but also by incorporation of oxygen as anionic component. This opens up the entire spectrum of use of luminescent substances, such as illumination systems or electronic screens.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: January 22, 2013
    Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Martin Jansen, Hasan Cakmak
  • Patent number: 8349993
    Abstract: Hydrolytically and thermo-oxidatively stable sulfonated polyarylenes include the structural element —X—Ar(SO3M)n-Y—. The aromatic ring carrying the sulfonic acid group is substituted exclusively by electron-acceptor bridge groups X and Y and, if applicable, by other non-electron-donor substituents. Their synthesis and application are also included.
    Type: Grant
    Filed: March 7, 2006
    Date of Patent: January 8, 2013
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Michael Schuster, Klaus-Dieter Kreuer, Henrik Thalbitzer Andersen, Joachim Maier
  • Patent number: 8344205
    Abstract: This invention relates generally to plant cells and/or plants with increased yield as compared to a corresponding non-transformed wild type plant cell by increasing or generating one or more activities of polypeptides associated with the intermediate phosphoribosylpyrophosphate (PRPP) in plants. In particular, this invention relates to plant cells and/or plants with increased yield as compared to a corresponding non-transformed wild type plant cell by increasing or generating one or more activities of phosphoribosyl pyrophosphate synthases (PRPP synthetase, PRS) The invention also deals with methods of producing and screening for and breeding such plant cells and/or plants.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: January 1, 2013
    Assignees: BASF Plant Science GmbH, Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Thorsten Zank, Oliver Oswald, Jörg Bauer, Rita Maria Zrenner, Silke Koslowsky
  • Patent number: 8339032
    Abstract: The invention relates to a light source comprising a primary radiation source and a luminescent substance, and to a method for producing this light source. The invention relates, in particular, to a method for producing an electric light source using one or more luminescent substances emitting in the visible spectrum range, and at least one primary source emitting preferably in the UV range, and which is preferably, but not exclusively, an LED.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: December 25, 2012
    Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventor: Martin Jansen
  • Patent number: 8338146
    Abstract: A process for preparing optically active alcohols of the formula Ia or Ib in which R1,R2 are alkyl, alkenyl, aryl, or alkylaryl groups which may in turn be substituted one or more times by alkyl, halogen, SH, SR2, OH, OR2, NO2, CN, CO, COOR2, NR2R3 or NR2R3R4+X, where R2, R3 and R4 are independently of one another H or a lower alkyl or lower alkoxy radical, and X?is a counter ion, with the proviso that R1 is not equal to R2, by reducing the corresponding ketone, where the reduction is carried out with a dehydrogenase having the polypeptide sequence of SEQ ID NO: 2 or NO: 4, or with a polypeptide sequence in which up to 25% of the amino acid residues are altered by comparison with SEQ ID NO: 2 or NO: 4 by deletion, insertion, substitution or a combination thereof.
    Type: Grant
    Filed: June 16, 2008
    Date of Patent: December 25, 2012
    Assignees: BASF SE, Albert-Ludwigs-Universitaet Freiburg, Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Michael Breuer, Ralf Rabus, Johann Heider
  • Patent number: 8334698
    Abstract: A sample holding device, adapted for holding a sample, like a rodent or an MR phantom sample in a magnet bore of a magnetic resonance tomography (MRT) device, comprises a sample carrier being adapted for an arrangement in the bore of the MRT device, wherein the sample carrier comprises a carrier platform for accommodating the sample and at least one clamping part with radial locking pieces being adapted for fixing the sample carrier in a hollow enclosure structure, wherein the at least one clamping part is connected with the carrier platform. Furthermore, an MRT device and a method of MRT imaging of a sample are described.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: December 18, 2012
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V., Biomedizinische NMR Forschungs GmbH
    Inventors: Roland Tammer, Susann Boretius, Thomas Michaelis, Andreas Pucher-Diehl
  • Patent number: 8329463
    Abstract: Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). Using a Drosophila in vitro system, we demonstrate that 19-23 nt short RNA fragments are the sequence-specific mediators of RNAi. The short interfering RNAs (siRNAs) are generated by an RNase III-like processing reaction from long dsRNA. Chemically synthesized siRNA duplexes with overhanging 3? ends mediate efficient target RNA cleavage in the lysate, and the cleavage site is located near the center of the region spanned by the guiding siRNA. Furthermore, we provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the produced siRNP complex.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: December 11, 2012
    Assignees: Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V., Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research, University of Massachusetts
    Inventors: Thomas Tuschl, Sayda Mahgoub Elbashir, Winfried Lendeckel
  • Patent number: 8310230
    Abstract: A method for sensing a microwave magnetic field polarization component of a microwave field generated by a microwave device, comprises the steps of generating a static magnetic field having a predetermined amplitude and a predetermined direction relative to the microwave magnetic field polarization component to be sensed, preparing an atom cloud of ultracold probe atoms in defined hyperfine levels, wherein the hyperfine levels of the probe atoms are split in transition frequencies by the static magnetic field, applying a microwave pulse including the microwave magnetic field polarization component to be sensed to the atom cloud, wherein a spatial state distribution of the probe atoms is created by Rabi oscillations during the microwave pulse between the hyperfine levels of the probe atoms being resonant with the microwave magnetic field polarization component, and collecting a state image of the probe atoms, said state image depending on the spatial state distribution of the probe atoms and representing the m
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: November 13, 2012
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V., Ludwig-Maximillians-Universitat Munchen
    Inventors: Theodor W. Haensch, Pascal Boehi, Max Riedel, Philipp Treutlein
  • Patent number: 8293084
    Abstract: The present invention relates to methods for the identification of compounds in carbohydrate mixture compositions as well as the determination of carbohydrate mixture composition patterns, based on e.g. orthogonal cross determining migration time (indices) using capillary gel electrophoresis-laser induced fluorescence and identifying said carbohydrate components based on comparing said migration time (indices) with standard migration time (indices) from a database which data are preferably also orthogonal cross determined. In a further aspect, the present invention relates to a method for carbohydrate mixture composition pattern profiling, like glycosylation pattern profiling using capillary gel electrophoresis-laser induced fluorescence (CGE-LIF). In another aspect, the present invention refers to a system for an automated determination and/or identification of carbohydrates and/or carbohydrate mixture composition patterns (e.g.: glycosylation patterns).
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: October 23, 2012
    Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Erdmann Rapp, Jana Schwarzer, Udo Reichl, Christian Bohne
  • Publication number: 20120258243
    Abstract: A method of producing a Fresnel zone plate (15) comprising: making available a substrate (1, 4, 7) which is rotationally symmetrical with respect to its centre axis (1a, 4a, 7a); applying layers (2a-d; 5a-d; 8a-d; 11) following in succession by means of an atomic layer deposition (ALD) method to faces (1b-c; 4b-c; 7b-c) of the substrate (1, 4, 7) without rotation of the substrate (1, 4, 7) in order to form a coated substrate, and severing (3a, b; 6a, b; 9a, b) at least one slice (13) from the coated substrate (1, 4, 7), by the coated substrate (1, 4, 7) being divided at least once at a right angle to the centre axis (1a, 4a, 7a).
    Type: Application
    Filed: October 15, 2010
    Publication date: October 11, 2012
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Gisela Schuetz, Corrine Grévent, Marcel Mayer, Brigitte Baretzky
  • Publication number: 20120230978
    Abstract: The present invention relates to a modulator of glucocorticoid biosynthesis, degradation and/or receptor activation for use in preventing or treating symptoms and/or diseases associated with jet lag. The compositions of the invention may be used as a lead compound for developing a drug for preventing or treating symptoms and/or diseases associated with jet lag. The invention relates to the discovery that administration of the modulator(s) to a subject results in a directional change of the time point of maximum amounts of glucocorticoids in the subject as compared to the time point of maximum amounts of glucocorticoids in a subject not treated with the modulator(s).
    Type: Application
    Filed: March 7, 2012
    Publication date: September 13, 2012
    Applicant: Max-Planck-Gesellschaft-zur-Forderung der Wissenschaften e.V.
    Inventors: Gregor Eichele, Henrik Oster, Silke Kiessling
  • Patent number: 8242298
    Abstract: The present invention relates to novel processes for preparing borylsilylamines, novel amines, novel borosilazane compounds, novel oligoborosilazane or polyborosilazane compounds which have the structural feature Si—N—B, ceramic material and methods of producing and using them.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: August 14, 2012
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Matthias Kroschel, Martin Jansen
  • Publication number: 20120202068
    Abstract: The invention relates to a process for the deposition of a metal oxide, such as titanium dioxide, as a thin layer on a substrate, by using particular biopolymers, in particular, a hydrophobin. The process for the deposition of a metal oxide on a substrate (S) comprises the steps of depositing a protein layer (H) comprising at least one hydrophobin on the substrate and the deposition of a metal oxide layer (M) on the protein layer (H) by precipitation from an aqueous solution of a metal salt.
    Type: Application
    Filed: February 2, 2012
    Publication date: August 9, 2012
    Applicants: BASF SE, UNIVERSITAET STUTTGART, MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: JOACHIM BILL, ZAKLINA BURGHARD, DEENAN SANTHYA
  • Patent number: 8231809
    Abstract: Rylene derivatives useful in solar cells, where the rylene derivatives are represented by formula I where each X group is joined to form a six-membered ring, one Y group is an amine group, one Y group is a hydrogen atom, each R group is an alkoxy group, m is 1, n is 4, and P is 0.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: July 31, 2012
    Assignees: BASF Aktiengesellschaft, Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Neil Gregory Pschirer, Felix Eickemeyer, Jan Schoeneboom, Jianqiang Qu, Martin Koenemann, Klaus Muellen, Chen Li, Andreas Herrmann, Peter Erk, Gero Nordmann, Alfred Kuhn, Anders Hagfeldt, Tomas Edvinsson
  • Patent number: 8232243
    Abstract: The invention relates to the use of tryptophan-containing, in particular tryptophan- and tyrosine-containing, peptides as antioxidants. The compounds can be used for the therapy or prophylaxis of syndromes and disorders associated with unwanted oxidative processes in the extracellular space.
    Type: Grant
    Filed: December 4, 2000
    Date of Patent: July 31, 2012
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Bernd Moosmann, Christian Behl